Medically reviewed by Michael MacIntyre, MD Treatment-resistant depression (TRD) occurs when major depressive disorder (MDD) ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Treatment-resistant depression is a term used to describe a form of major depressive disorder ... The amygdala is a small, almond-shaped structure in the brain’s temporal lobe that is involved in ...

Roche has entered into an agreement with Evotec to fund the Phase II clinical development of a selective N-methyl-D-aspartate (NMDA) receptor antagonist, EVT 101, for patients with treatment ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Psilocybin therapy -- used to treat a range of mental health conditions, such as depression, anxiety, and addictions -- can ...

Three versions of synthetic psilocybin have received the US Food and Drug Administration’s “breakthrough therapy” designation — in 2018 for treatment-resistant depression, which is ...

By targeting complex conditions such as treatment-resistant depression, social anxiety disorder and opioid use disorder, Atai aims to address significant gaps in the mental health treatment landscape.

The United States Food and Drug Administration cleared the investigational new drug application for VLS-01 (buccal film DMT); atai expects to ...